#Dioseve, a Tokyo, Japan and Palo Alto, Calif.-based fertility biotech company, raised $7 million in a Series A extension. Archetype Ventures led the round and was joined by Shionogi, Pangaea Ventures, D4V, DGDaiwa Ventures, and Mirai Creation Fund.
#healthcare